^
Association details:
Biomarker:No biomarker
Cancer:Peripheral T-cell Lymphoma
Drug:etoposide IV (Topoisomerase II inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Peripheral T-cell Lymphoma: Second-line or initial palliative intent therapy (no intention to transplant) and subsequent therapy...Other recommended regimens…Cyclophosphamide and/or etoposide (IV or PO)